A Single-Arm Study of Sintilimab and Disitamab Vedotin for Locally Advanced Eyelid Sebaceous Gland Carcinoma

NCT07740993 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Sebaceous Gland Carcinoma

Interventions

DRUG: Sintilimab
DRUG: disitamab vedotin

Sponsor

West China Hospital